FI875427A - Menetelmä valmistaa hevosen -interferonia - Google Patents

Menetelmä valmistaa hevosen -interferonia Download PDF

Info

Publication number
FI875427A
FI875427A FI875427A FI875427A FI875427A FI 875427 A FI875427 A FI 875427A FI 875427 A FI875427 A FI 875427A FI 875427 A FI875427 A FI 875427A FI 875427 A FI875427 A FI 875427A
Authority
FI
Finland
Prior art keywords
gamma
eqifn
polypeptide
relates
sequences
Prior art date
Application number
FI875427A
Other languages
English (en)
Swedish (sv)
Other versions
FI875427A0 (fi
FI99116C (fi
FI99116B (fi
Inventor
Rudolf Hauptmann
Adolf Himmler
Peter Swetly
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI875427A0 publication Critical patent/FI875427A0/fi
Publication of FI875427A publication Critical patent/FI875427A/fi
Application granted granted Critical
Publication of FI99116B publication Critical patent/FI99116B/fi
Publication of FI99116C publication Critical patent/FI99116C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI875427A 1986-12-10 1987-12-10 Menetelmä valmistaa hevosen -interferonia FI99116C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863642096 DE3642096A1 (de) 1986-12-10 1986-12-10 Pferde-(gamma)-interferon
DE3642096 1986-12-10

Publications (4)

Publication Number Publication Date
FI875427A0 FI875427A0 (fi) 1987-12-10
FI875427A true FI875427A (fi) 1988-06-11
FI99116B FI99116B (fi) 1997-06-30
FI99116C FI99116C (fi) 1997-10-10

Family

ID=6315829

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875427A FI99116C (fi) 1986-12-10 1987-12-10 Menetelmä valmistaa hevosen -interferonia

Country Status (20)

Country Link
US (1) US5602010A (fi)
EP (1) EP0271824B1 (fi)
JP (3) JPS63233794A (fi)
KR (1) KR880007568A (fi)
AT (1) ATE91722T1 (fi)
AU (1) AU616873B2 (fi)
CA (1) CA1339776C (fi)
DE (2) DE3642096A1 (fi)
DK (1) DK170054B1 (fi)
ES (1) ES2058094T3 (fi)
FI (1) FI99116C (fi)
HU (1) HU213566B (fi)
IE (1) IE60404B1 (fi)
IL (1) IL84780A (fi)
NO (1) NO180239C (fi)
NZ (1) NZ222856A (fi)
PH (1) PH30889A (fi)
PT (1) PT86332B (fi)
SU (1) SU1701114A3 (fi)
ZA (1) ZA879245B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2687995B2 (ja) 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Ｄｎａ配列、組替えｄｎａ分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
US6307025B1 (en) 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US5272263A (en) 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
GB2291645A (en) * 1994-07-21 1996-01-31 Q One Biotech Ltd Equine gamma-interferon
EP1450836A4 (en) * 2000-11-03 2007-07-25 Intarcia Therapeutics Inc PROCESS FOR SHORT AND LONG-TERM DOSAGE OF MEDICAMENTS
US20030143197A1 (en) * 2001-11-09 2003-07-31 Moran S. Mark Method for treating diseases with omega interferon
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
CN105688191A (zh) 2007-04-23 2016-06-22 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
MX352878B (es) 2009-09-28 2017-12-13 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
JP6993235B2 (ja) 2015-06-03 2022-01-13 インターシア セラピューティクス，インコーポレイティド インプラントの設置及び撤去システム
EP3458084B1 (en) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE88622C (fi) *
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity

Also Published As

Publication number Publication date
PT86332B (pt) 1990-11-07
FI875427A0 (fi) 1987-12-10
US5602010A (en) 1997-02-11
KR880007568A (ko) 1988-08-27
FI99116C (fi) 1997-10-10
NO875136L (no) 1988-06-13
NO875136D0 (no) 1987-12-09
SU1701114A3 (ru) 1991-12-23
ZA879245B (en) 1989-08-30
NO180239B (no) 1996-12-02
DE3642096A1 (de) 1988-06-16
ES2058094T3 (es) 1994-11-01
AU8223387A (en) 1988-06-30
NO180239C (no) 1997-03-12
PH30889A (en) 1997-12-23
IE873342L (en) 1988-06-10
CA1339776C (en) 1998-03-24
IL84780A0 (en) 1988-05-31
HUT46066A (en) 1988-09-28
ATE91722T1 (de) 1993-08-15
NZ222856A (en) 1991-11-26
FI99116B (fi) 1997-06-30
EP0271824A2 (de) 1988-06-22
DK170054B1 (da) 1995-05-08
JPH07258294A (ja) 1995-10-09
IE60404B1 (en) 1994-07-13
AU616873B2 (en) 1991-11-14
HU213566B (en) 1997-08-28
JPH07250690A (ja) 1995-10-03
IL84780A (en) 1992-11-15
DK645887D0 (da) 1987-12-09
JPS63233794A (ja) 1988-09-29
PT86332A (de) 1988-01-01
EP0271824B1 (de) 1993-07-21
EP0271824A3 (en) 1989-05-24
DK645887A (da) 1988-06-11
DE3786649D1 (de) 1993-08-26

Similar Documents

Publication Publication Date Title
FI99116B (fi) Menetelmä valmistaa hevosen -interferonia
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ATE109205T1 (de) Verbesserung der ausbeute bei der sekretion von disulfidverbrückten proteinen.
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
DK491487D0 (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DK595187D0 (da) Minactivin og fremgangsmaade til fremstilling deraf
EP0215110A4 (en) MANUFACTURING SOMATOMEDIN C.
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
DK128687A (da) Proteiner samt deres fremstilling og anvendelse
DK415589D0 (da) Genekspressionsregulerende faktor
DK210288A (da) Overproduktion af exocelllulaere proteiner

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH